Advertisement

Topics

Amgen, Allergan Get Positive CHMP Opinion For ABP 215, Biosimilar Bevacizumab

07:53 EST 10 Nov 2017 | FinanzNachrichten

THOUSAND OAKS (dpa-AFX) - Amgen (AMGN) and Allergan plc. (AGN) announced that the Committee for Medicinal Products for Human Use or CHMP of the European Medicines Agency has adopted a positive opi...

Original Article: Amgen, Allergan Get Positive CHMP Opinion For ABP 215, Biosimilar Bevacizumab

NEXT ARTICLE

More From BioPortfolio on "Amgen, Allergan Get Positive CHMP Opinion For ABP 215, Biosimilar Bevacizumab"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...